Published in Cell Biosci on February 17, 2014
Roles of the Y chromosome genes in human cancers. Asian J Androl (2015) 0.78
Y-chromosomal genes affecting male fertility: A review. Vet World (2016) 0.77
Ninety-day oral toxicity studies on two genetically modified maize MON810 varieties in Wistar Han RCC rats (EU 7th Framework Programme project GRACE). Arch Toxicol (2014) 2.91
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 2.00
TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat (2006) 1.93
Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science (2002) 1.87
Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective. Eur J Hum Genet (2003) 1.69
Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives. Eur J Hum Genet (2008) 1.63
Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer (2010) 1.58
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin. Cancer Res (2002) 1.55
The importance of genetic testing in the clinical management of patients with Marfan syndrome and related disorders. Dtsch Arztebl Int (2008) 1.49
Enhancement of human sperm motility by trophinin binding peptide. J Urol (2008) 1.48
Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet (2010) 1.47
Community genetics. Its definition 2010. J Community Genet (2010) 1.42
Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A (2009) 1.32
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Glycobiology (2007) 1.31
Potentials and limits of pairwise kinship analysis using autosomal short tandem repeat loci. Int J Legal Med (2010) 1.24
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet (2011) 1.23
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. Transplantation (2004) 1.22
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene. Br J Haematol (2008) 1.20
Reduction of spermatogenesis but not fertility in Creb3l4-deficient mice. Mol Cell Biol (2005) 1.20
The wide variation of definitions of genetic testing in international recommendations, guidelines and reports. J Community Genet (2012) 1.19
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. EMBO J (2011) 1.18
The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe. Eur J Hum Genet (2012) 1.18
Genetic admixture history of Eastern Indonesia as revealed by Y-chromosome and mitochondrial DNA analysis. Mol Biol Evol (2009) 1.17
Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat (2005) 1.14
A longitudinal study of age-specific reproductive output and body condition among male rhesus macaques, Macaca mulatta. Naturwissenschaften (2003) 1.12
Scope of definitions of genetic testing: evidence from a EuroGentest survey. J Community Genet (2010) 1.11
Definitions of genetic testing in European legal documents. J Community Genet (2012) 1.10
Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology (2005) 1.08
Clinical utility gene card for: Loeys-Dietz syndrome (TGFBR1/2) and related phenotypes. Eur J Hum Genet (2011) 1.07
The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A (2008) 1.06
The journal of community genetics. J Community Genet (2010) 1.06
Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem (2009) 1.06
Putative human male germ cells from bone marrow stem cells. Soc Reprod Fertil Suppl (2007) 1.04
Patient compliance based on genetic medicine: a literature review. J Community Genet (2013) 1.04
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. Cancer Lett (2003) 1.04
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study. Int J Clin Oncol (2012) 1.02
Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res (2003) 1.01
What is ideal genetic counselling? A survey of current international guidelines. Eur J Hum Genet (2008) 0.99
An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. Int J Urol (2009) 0.99
Two opposing roles of O-glycans in tumor metastasis. Trends Mol Med (2012) 0.99
Multiple sirehood in free-ranging twin rhesus macaques (Macaca mulatta). Am J Primatol (2002) 0.99
Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations. Hum Mutat (2002) 0.98
Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria. BJU Int (2013) 0.97
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. Int J Oncol (2012) 0.97
Hspa4l-deficient mice display increased incidence of male infertility and hydronephrosis development. Mol Cell Biol (2006) 0.97
The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol (2007) 0.97
The EuroGentest Clinical Utility Gene Cards continued. Eur J Hum Genet (2013) 0.97
Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report. BMC Urol (2013) 0.96
Branched and linear poly(ethylene imine)-based conjugates: synthetic modification, characterization, and application. Chem Soc Rev (2012) 0.95
FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages. J Biol Chem (2009) 0.95
Frequency of postoperative inguinal hernia after endoscope-assisted mini-laparotomy and conventional retropubic radical prostatectomies. Int J Urol (2008) 0.95
Primary choriocarcinoma in the posterior mediastinum. J Urol (2002) 0.94
Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today (2009) 0.93
Experience and functional outcome of modified ileal neobladder in 95 patients. Int J Urol (2006) 0.93
N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res (2006) 0.93
Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med (2002) 0.92
Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics. Bioconjug Chem (2011) 0.92
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer (2003) 0.92
Male reproductive timing in Rhesus macaques is influenced by the 5HTTLPR promoter polymorphism of the serotonin transporter gene. Biol Reprod (2005) 0.91
On the testing load incurred by cascade genetic carrier screening for Mendelian disorders: a brief report. Genet Test (2007) 0.91
Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study. Urology (2008) 0.91
Points to consider in assessing and appraising predictive genetic tests. J Community Genet (2010) 0.91
JKT-1 is not a human seminoma cell line. Int J Androl (2007) 0.90
A gene conversion hotspot in the human growth hormone (GH1) gene promoter. Hum Mutat (2009) 0.90
Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells. Int J Cancer (2003) 0.89
Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor. Cancer Res (2004) 0.89
Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol (2002) 0.89
A very long foreign body in the bladder. Adv Urol (2011) 0.89
The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer. Int J Cancer (2007) 0.89
Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease. Int J Nephrol (2012) 0.89
[A case of retroperitoneal extramedullary plasmacytoma]. Hinyokika Kiyo (2003) 0.88
Genetic education and nongenetic health professionals: educational providers and curricula in Europe. Genet Med (2005) 0.88
Clinical significance of ST3Gal IV expression in human renal cell carcinoma. Oncol Rep (2002) 0.88
Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis (2003) 0.88
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Int Urol Nephrol (2015) 0.87
PIAS1 interacts with and represses SOX9 transactivation activity. Mol Reprod Dev (2007) 0.87
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center. BMC Urol (2013) 0.87
Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci (2012) 0.86
Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients. Int J Urol (2008) 0.86
Twin study on heritability of activity, attention, and impulsivity as assessed by objective measures. J Atten Disord (2006) 0.86
Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experiments. Eur J Hum Genet (2013) 0.86
Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer (2002) 0.86
Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide. Proc Natl Acad Sci U S A (2011) 0.86
Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells. Proc Natl Acad Sci U S A (2009) 0.86
Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice. J Biochem (2009) 0.86
Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer. Prostate (2014) 0.86